TIANJIN DEV: Annual Report 2024

HKEXApr 27 18:03 ET · Announcements

Lisheng Pharmaceutical's Profit Slips in Q1

MT NewswiresApr 25 06:14 ET

Express News | Tianjin Development - Qtrly Total Operating Income of Tianjin Lisheng Pharmaceutical RMB369.8 Mln

ReutersApr 25 00:05 ET

TIANJIN DEV: Unaudited Financial Results for the three months ended 31 March 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd.

HKEXApr 25 00:04 ET · Announcements

TIANJIN DEV (00882) announced its annual results, with a profit attributable to shareholders of 0.548 billion HKD, a year-on-year decrease of 13.78%. It plans to declare a final dividend of 8.82 HK cents per share.

TIANJIN DEV (00882) announced its annual results for the year ending December 31, 2024, with group revenue of 33.59...

Zhitong FinanceMar 28 00:20 ET

Express News | Tianjin Development Holdings FY Net Income HKD 548.1 Million

ReutersMar 28 00:05 ET

Express News | Tianjin Development - Proposed Final Dividend of HK8.82 Cents per Share

ReutersMar 28 00:05 ET

TIANJIN DEV: Announcement of Final Results for the year ended 31 December 2024

HKEXMar 28 00:04 ET · Announcements

Tianjin Lisheng's Profit Falls in 2024; Shares Down 3%

MT NewswiresMar 20 21:47 ET

TIANJIN DEV (00882): Tianjin Lisheng Pharmaceutical (002393.SZ) had a net income of 0.185 billion yuan for the year 2024, a decrease of 49% year-on-year.

TIANJIN DEV (00882) announced Tianjin Lisheng Pharmaceutical (002393.SZ) as of December 31, 2024...

Zhitong FinanceMar 20 18:20 ET

TIANJIN DEV: Audited Financial Results for the year ended 31 December 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

HKEXMar 20 18:08 ET · Announcements

TIANJIN DEV: Date of Board Meeting

HKEXMar 17 00:01 ET · Announcements

Tianjin Lisheng Pharmaceutical Buys Back Shares Worth 129 Million Yuan

MT NewswiresFeb 6 03:27 ET

TIANJIN DEV (00882.HK): Xia Binhui has been appointed as Executive Director and Deputy General Manager.

Gelonghui reported on December 30 that TIANJIN DEV (00882.HK) announced that the Board of Directors has appointed Xia Binhui as the company's executive director and deputy general manager, effective from December 30, 2024.

Gelonghui FinanceDec 30, 2024 04:56 ET

TIANJIN DEV (00882): Xia Binhui has been appointed as Executive Director.

TIANJIN DEV (00882) announced that Xia Binhui has been appointed as the company's executive Director and vice general manager, starting from 2024...

Zhitong FinanceDec 30, 2024 04:56 ET

Express News | Tianjin Development Holdings Ltd - Xia Binhui Appointed as Executive Director

ReutersDec 30, 2024 04:55 ET

Tianjin Development Subsidiary to Repurchase Shares, Grant Shares Under Share Award Scheme

MT NewswiresDec 23, 2024 03:19 ET

Tianjin DEV (00882.HK) subsidiary Tianjin Lisheng Pharmaceutical plans to repurchase shares and adopt a stock incentive plan.

On December 20, Grizzly Holdings announced that TIANJIN DEV (00882.HK) has approved a share buyback plan at the Board of Directors of Tianjin Lisheng Pharmaceutical (a non-wholly-owned subsidiary indirectly listed on the Shenzhen Stock Exchange) on December 20, 2024. Accordingly, starting from December 21, 2024, within a period of twelve months, Tianjin Lisheng Pharmaceutical is allowed to repurchase its ordinary shares through centralized bidding on the Shenzhen Stock Exchange at the current market price, with a total amount not less than 76.5 million yuan and not exceeding 0.153 billion yuan. The Board of Directors of Tianjin Lisheng Pharmaceutical recommends that this be approved by its Shareholders at the Shareholders' meeting.

Gelonghui FinanceDec 20, 2024 08:57 ET

Express News | Tianjin Development - Unit to Conduct Repurchase of Ordinary Shares for Not Less Than RMB76.5 Mln and up to RMB153 Mln

ReutersDec 20, 2024 08:53 ET

Express News | Tianjin Development -Co to Borrow From Revolving Loan Facility of HK$100 Mln

ReutersDec 11, 2024 04:53 ET